Truist Financial’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.19M Sell
9,074
-142
-2% -$34.3K ﹤0.01% 1226
2025
Q1
$2.24M Buy
9,216
+30
+0.3% +$7.31K ﹤0.01% 1164
2024
Q4
$3.02M Buy
9,186
+72
+0.8% +$23.7K ﹤0.01% 1046
2024
Q3
$3.05M Buy
9,114
+183
+2% +$61.2K ﹤0.01% 1043
2024
Q2
$2.44M Sell
8,931
-1,742
-16% -$476K ﹤0.01% 1175
2024
Q1
$3.69M Sell
10,673
-962
-8% -$333K 0.01% 999
2023
Q4
$3.76M Sell
11,635
-3,184
-21% -$1.03M 0.01% 971
2023
Q3
$5.31M Buy
14,819
+31
+0.2% +$11.1K 0.01% 822
2023
Q2
$5.61M Buy
14,788
+2,046
+16% +$776K 0.01% 793
2023
Q1
$6.1M Buy
12,742
+309
+2% +$148K 0.01% 751
2022
Q4
$5.23M Buy
12,433
+2,543
+26% +$1.07M 0.01% 806
2022
Q3
$4.13M Buy
9,890
+516
+6% +$215K 0.01% 857
2022
Q2
$4.64M Sell
9,374
-1,107
-11% -$548K 0.01% 830
2022
Q1
$5.9M Sell
10,481
-1,315
-11% -$741K 0.01% 827
2021
Q4
$8.91M Sell
11,796
-570
-5% -$431K 0.01% 680
2021
Q3
$9.22M Buy
12,366
+298
+2% +$222K 0.02% 667
2021
Q2
$7.78M Sell
12,068
-98
-0.8% -$63.1K 0.01% 720
2021
Q1
$6.95M Buy
12,166
+992
+9% +$567K 0.01% 724
2020
Q4
$6.51M Sell
11,174
-900
-7% -$525K 0.01% 736
2020
Q3
$6.22M Sell
12,074
-1,200
-9% -$619K 0.01% 688
2020
Q2
$5.99M Buy
13,274
+755
+6% +$341K 0.01% 672
2020
Q1
$4.39M Buy
12,519
+106
+0.9% +$37.2K 0.01% 707
2019
Q4
$4.59M Buy
12,413
+10,953
+750% +$4.05M 0.01% 773
2019
Q3
$486K Sell
1,460
-43
-3% -$14.3K 0.01% 572
2019
Q2
$469K Buy
1,503
+47
+3% +$14.7K 0.01% 595
2019
Q1
$445K Buy
1,456
+144
+11% +$44K 0.01% 593
2018
Q4
$304K Buy
1,312
+177
+16% +$41K 0.01% 640
2018
Q3
$355K Sell
1,135
-285
-20% -$89.1K 0.01% 652
2018
Q2
$410K Buy
+1,420
New +$410K 0.01% 618